Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
Language English Country England, Great Britain Media print-electronic
Document type Practice Guideline, Research Support, Non-U.S. Gov't, Journal Article
PubMed
36307055
DOI
10.1016/j.annonc.2022.10.004
PII: S0923-7534(22)04193-X
Knihovny.cz E-resources
- Keywords
- BRCA, ESMO Clinical Practice Guideline, hereditary breast and ovarian cancer syndromes, risk reduction,
- MeSH
- Early Detection of Cancer MeSH
- Risk Reduction Behavior MeSH
- Neoplastic Syndromes, Hereditary * MeSH
- Genetic Predisposition to Disease MeSH
- Humans MeSH
- Breast Neoplasms * diagnosis genetics prevention & control MeSH
- Ovarian Neoplasms * diagnosis epidemiology genetics MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
Basser Center for BRCA Abramson Cancer Center University of Pennsylvania Philadelphia USA
Champalimaud Foundation Breast Unit and Faculdade de Medicina Lisbon Portugal
Department of Oncology UCL Cancer Institute University College London and UCL Hospitals London UK
GBG Forschungs GmbH Neu Isenburg Germany
Medical Oncology Oncology Institute of Southern Switzerland EOC Bellinzona Switzerland
References provided by Crossref.org